KM and Cox regression analyses showed that high HS6ST2 expression was associated with worse DFI in lung adenocarcinoma and kidney renal papillary cell carcinoma and with better DFI in bladder urothelial carcinoma (Fig. 5A–D). This evidence concerns the gene HS6ST2 and bladder transitional cell carcinoma.